CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XIV. APPRAISAL OF ISOHEMAGGLUTININ ACTIVITY

^{Department of Internal Medicine, College of Medicine, State University of Iowa, Iowa City}

The products of plasma fractionation employed in this work were developed from blood, collected by the American Red Cross, by the Department of Physical Chemistry, Harvard Medical School, Boston, Massachusetts, under a contract, recommended by the Committee on Medical Research, between the Office of Scientific Research and Development and Harvard University.

Find articles by DeGowin, E. in: PubMed | Google Scholar